Effects of incentive spirometry with and without aerobic exercises in interstitial lung disease
Effects of Incentive Spirometry With and Without Aerobic Exercises on Dyspnea, Exercise Capacity and Quality of Life in Interstitial Lung Disease
This study is testing whether combining incentive spirometry with aerobic exercises can help people with interstitial lung disease breathe better and improve their quality of life compared to using spirometry alone.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 32 (estimated) |
| Ages | 18 Years to 55 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Lahore, Punjab) |
| Trial ID | NCT06133998 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of incentive spirometry combined with aerobic exercises versus incentive spirometry alone on patients with interstitial lung disease. It aims to assess improvements in dyspnea, exercise capacity, and quality of life among participants. The study will involve 32 patients who will be randomly assigned to either an aerobic exercise group or a control group receiving only spirometry treatment. Various assessments, including the 6-minute walk test and quality of life questionnaires, will be utilized to evaluate outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 55 diagnosed with interstitial lung disease who are clinically stable.
Not a fit: Patients with other significant respiratory disorders or comorbidities that prevent exercise training may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance the quality of life and physical capabilities of patients suffering from interstitial lung disease.
How similar studies have performed: While similar approaches have been explored, this specific combination of incentive spirometry and aerobic exercises in interstitial lung disease is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients18 to 55 years of age (21) * Both gender(M/F) * Diagnosed as ILD ( sarcoidosis,acute interstitial pneumonia etc.)on clinical, radiological, and histopathological basis * All included patients were clinically stable without exacerbations in the past 1 month. Exclusion Criteria: * Patients with other significant respiratory disorders such as acute infections, pulmonary tuberculosis, COPD, asthma, bronchiectasis, lung carcinoma, and pneumothorax * connective tissue disease-associated ILD * Patients having other co morbid diseases preventing from exercise training, for example, disability due to orthopedic, neurological, and acute cardiac causes * Physically and mentally unwell to attend the hospital for training * Already completed or participated in a PR program in the past 1 year
Where this trial is running
Lahore, Punjab
- Ittefaq Hospital — Lahore, Punjab, Pakistan (Recruiting)
Study contacts
- Principal investigator: sumera abdul hameed, Ms — Riphah International University
- Study coordinator: imran amjad, phd
- Email: imran.amjad@riphah.edu.pk
- Phone: 03324390125
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.